|
Real-time Estimate
Cboe BZX
15:28:31 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 1.225 USD | +2.94% |
|
+7.14% | -66.48% |
| Market Cap | 7.22M 6.45M 5.95M 5.4M 10.14M 684M 10.3M 71.67M 28.23M 359M 27.12M 26.54M 1.14B | P/E 2025 |
-1.44x | P/E 2026 | -0.7x |
|---|---|---|---|---|---|
| Enterprise Value | 49.81M 44.46M 41.02M 37.26M 69.91M 4.72B 70.98M 494M 195M 2.47B 187M 183M 7.83B | EV / Sales 2025 |
0.52x | EV / Sales 2026 | 0.4x |
| Free-Float |
51.02% | Yield 2025 * |
-
| Yield 2026 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NAII | Delayed | |
CBOE
| NAII | Real-time | |
Deutsche Boerse AG
| NA2 | Delayed | |
Börse Stuttgart
| NA2 | Delayed | |
Boerse Muenchen
| NA2 | Real-time |
| 1 day | +2.94% | ||
| 1 week | +7.14% | ||
| Current month | -19.46% | ||
| 1 month | -36.84% | ||
| 3 months | -49.58% | ||
| 6 months | -57.14% | ||
| Current year | -66.48% |
| 1 week | 1.14 | 1.26 | |
| 1 month | 1.08 | 1.95 | |
| Current year | 1.08 | 4.96 | |
| 1 year | 1.08 | 4.96 | |
| 3 years | 1.08 | 7.37 | |
| 5 years | 1.08 | 15 | |
| 10 years | 0 | 19.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CEO | Chief Executive Officer | 72 | 1985-12-31 |
Kenneth Wolf
DFI | Director of Finance/CFO | 65 | 2026-05-14 |
Nancy Steely
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CHM | Chairman | 72 | 2000-12-31 |
Alan Dunn
BRD | Director/Board Member | 71 | 2003-12-31 |
Laura Matherly
BRD | Director/Board Member | 62 | 2019-12-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/26 | Free | Director | 8,000 | 0.1295% | ||
| 3/6/26 | Tax | Chief Financial Officer | 20,151 | 0.3262% | ||
| 3/6/26 | Free | Director | 8,000 | 0.1295% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.94% | +7.14% | -54.55% | -79.83% | 7.22M | ||
| +3.17% | +4.64% | +61.21% | +127.12% | 1,133B | ||
| +4.16% | +6.11% | +39.29% | +77.52% | 621B | ||
| +0.04% | +0.54% | +24.60% | +96.88% | 503B | ||
| +0.03% | +3.27% | +39.79% | +65.06% | 379B | ||
| -0.56% | +2.04% | +69.10% | +43.35% | 370B | ||
| +1.58% | +2.37% | +22.91% | +52.52% | 292B | ||
| +2.90% | +2.22% | +3.51% | +28.51% | 262B | ||
| +2.46% | +3.52% | +51.80% | +64.54% | 237B | ||
| +2.03% | -0.36% | +29.10% | +102.17% | 190B | ||
| Average | +1.85% | +2.98% | +28.68% | +57.78% | 398.8B | |
| Weighted average by Cap. | +2.03% | +3.73% | +43.18% | +85.05% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 130M 116M 107M 97.15M 182M 12.3B 185M 1.29B 507M 6.44B 487M 477M 20.42B | 143M 127M 117M 107M 200M 13.5B 203M 1.41B 557M 7.07B 535M 523M 22.41B |
| Net income | -13.58M -12.12M -11.18M -10.16M -19.05M -1.29B -19.35M -135M -53.05M -674M -50.96M -49.86M -2.13B | -20.7M -18.47M -17.04M -15.48M -29.05M -1.96B -29.49M -205M -80.87M -1.03B -77.68M -76.02M -3.25B |
| Net Debt | 46.7M 41.69M 38.46M 34.94M 65.55M 4.42B 66.56M 463M 183M 2.32B 175M 172M 7.34B | 42.58M 38.01M 35.07M 31.86M 59.77M 4.03B 60.69M 422M 166M 2.11B 160M 156M 6.7B |
Employees
301
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | US$1.200 | +0.84% | 11,979 |
| 26-10-21 | US$1.190 | +2.59% | 1,972 |
| 26-10-20 | US$1.160 | +0.87% | 54,349 |
| 26-10-19 | US$1.150 | 0.00% | 11,327 |
| 26-10-16 | US$1.150 | +2.68% | 25,549 |
- Stock Market
- Stocks
- NAII Stock
Select your edition
All financial news and data tailored to specific country editions

















